Suggestions
Dawn Bell, PharmD
Founder, CEO, Board Director
Dawn Bell, PharmD is a seasoned professional in the life sciences industry with extensive experience in both biotech and pharmaceutical sectors. She is currently serving as the Chief Executive Officer at Antlia Bioscience, Inc.1
Career Highlights
Biotech and Pharmaceutical Experience: Dr. Bell has a diverse background that spans both biotech and big pharma. She spent time at Novartis, one of the world's largest pharmaceutical companies, with the intention of gaining a deeper understanding of biotech's primary customer - Big Pharma. Her plan was to work there for 3-5 years before returning to the biotech sector.2
Business Development: Dawn Bell has a track record of starting and scaling life-science businesses, leveraging her academic experience to drive innovation in the industry.1 Her expertise extends to building significant value in the pharmaceutical sector, as evidenced by her involvement in projects that have generated substantial returns.4
Industry Involvement
Board Positions: Dr. Bell serves on the board of directors for TMIC (likely referring to a biotech or pharmaceutical organization), currently in her second term. This appointment highlights her specialized contributions to the field.5
Conference Participation: She is actively involved in industry events and conferences. Dawn has participated in the European Society of Cardiology meeting and shown interest in the JP Morgan Healthcare Conference (JPM Week).34 Most recently, she expressed enthusiasm about attending the New York BIO's Innovation Summit, demonstrating her ongoing engagement with the biotech community.6
Areas of Interest
Dr. Bell appears to have a keen interest in emerging technologies and their applications in the life sciences sector. Her LinkedIn posts indicate involvement or interest in:
- Omics (likely referring to fields like genomics, proteomics, etc.)
- Artificial Intelligence in healthcare
- Startup ecosystems in the biotech industry5
Through her career trajectory and current role as CEO of Antlia Bioscience, Inc., Dawn Bell, PharmD has established herself as a prominent figure in the biotech and pharmaceutical industries, with a focus on innovation, business development, and leveraging cutting-edge technologies to advance healthcare solutions.